Start date
End date
A comprehensive collection of CRISPR tools and protocols for engineering Streptomyces is now available in Nature Protocols.
Danish biotech start-up will use technology to purify genetic materials to screen and analyse coronavirus test samples.
Stories: 750 M DKK renewal grant for sustainable research, Great potential in regulating plant greenhouse gas emissions (and using this knowledge in biotech), Balancing...
Denmark’s largest foundation, The Novo Nordisk Foundation, has awarded a grant of EUR 100 million to DTU Biosustain, paving the way for the development of new sustainable...
Since the beginning of April, intensive work has been done to set up a testing line at DTU aimed at increasing the COVID-19 test capacity in the Capital Region of Denmark...
A new research-based framework lets companies make informed decisions balancing economic and sustainability factors when producing biochemicals.
New discoveries on the regulation of plant emissions of isoprenoids can help in fighting climate change – and can become key to the production of valuable green chemicals...
The drug Niclosamide will now be clinically tested for treating coronavirus. DTU Professor Morten Sommer is looking forward to testing the drug in collaboration with a...
The young company Accelerbiotics has received 470,000 DKK to develop two new platforms for quicker analysis done in large scale by medical companies, in research and at...
Researchers from DTU have revealed the structure of an enzyme that can convert low-cost sugars into hard-to-produce alpha-GalNAc sugars with therapeutic properties for...
In a very short amount of time, researchers at DTU have succeeded in producing enzymes that are used in corona tests.
By linking thousands of cellular tell-tale molecules, the metabolic model Human1 can assist researchers in developing diagnostic tools and drugs against diseases such as...
In this issue, you can read no less than three articles about the magic world of mushrooms and some of the promising compounds they contain. In this edition, we also have...
Scientists from DTU Biosustain prove that psilocybin, a potential drug for treating depression and other psychological conditions can be produced in yeast.
To increase the number of coronavirus tests, Rigshospitalet will enter into an agreement with DTU, which has equipment for and experience in quick and secure handling of...
The lack of common standards and problems with reproducing and verifying existing datasets are widespread in the biotech community. However, a new tool named Memote paves...
DTU spin-out Cysbio has developed technology that can produce selected biochemicals through a simple fermentation process of sugar. This will limit use of fossil resources...
EPO, an important drug for treating anemia, can now be produced in higher quantities and with better quality in mammalian cells designed using CRISPR.
A new study in rats suggests that the natural antioxidant L-ergothioneine could alleviate the characteristics of pre-eclampsia. Researchers at DTU Biosustain work to produce...
In this issue, we focus on how big data and new promising tools such as ALE contribute to the development of sustainable alternatives to petrochemical production.